GEN-MKT-18-7897-A
Dec 19, 2019 | Blogs, Pharma | 0 comments
Over the last several years there has been a slow and steady progression within the LC-MS community to move traditional high-flow applications to lower flow rates. In particular, moving into the microflow regime has proven to be a simple adjustment in methodology that can result in a lot of gain for only a little pain. Microflow chromatography can provide an instant boost in sensitivity because of the increased ionization efficiency at lower flow rates. Additionally, microflow chromatography can lower solvent consumption and reagent costs and reduce downtime spent on routine instrument cleaning.
In the recent webinar Microflow Chromatography: The Key to More Sensitive Met ID, we discuss the benefits of microflow chromatography for metabolite ID applications. We compare microflow versus high flow for the identification of metabolites from several well-characterized drugs. The results are clear. Microflow provides:
As a follow-up to the webinar, we wanted to take the opportunity to answer some questions we received about using microflow for metabolite ID. After watching the presentation and reading our answers, we hope you will be convinced to consider microflow chromatography for your metabolite ID applications, too.
In monoclonal antibody (mAb) development, assessment of purity and integrity of the protein in question is critical. CE‑SDS is the gold standard assay and is routinely run from analytical development through QC and lot release. It’s trusted because it consistently delivers quantitative, size‑based insight into purity and fragmentation, and it fits naturally into regulated environments.
In drug discovery and development, Metabolite Identification (Met ID) plays a critical role in understanding biotransformation pathways, ensuring safety, and meeting regulatory requirements. Advanced mass spectrometry techniques have revolutionized this process, particularly through electron-based fragmentation methods such as Electron Activated Dissociation (EAD) and Electron Transfer Dissociation (ETD). While both techniques leverage electron interactions to generate informative fragment ions, they differ significantly in mechanism, performance, and suitability for Met ID workflows.
In analytical laboratories, performance is not optional. Whether supporting regulated pharmaceutical workflows, high-throughput CRO operations, clinical reporting, or food and environmental testing, your mass spectrometry and capillary electrophoresis systems are critical to productivity, compliance, and scientific confidence.
Posted by
You must be logged in to post a comment.
Share this post with your network